These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24735138)

  • 1. Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' reply.
    Wong GL; Wong VW
    Aliment Pharmacol Ther; 2014 May; 39(10):1236-7. PubMed ID: 24735138
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B.
    Miller M; Heron T; Dillon J
    Aliment Pharmacol Ther; 2014 May; 39(10):1236. PubMed ID: 24735137
    [No Abstract]   [Full Text] [Related]  

  • 3. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations.
    Wong GL; Chan HL; Yu Z; Chan AW; Choi PC; Chim AM; Chan HY; Tse CH; Wong VW
    Aliment Pharmacol Ther; 2014 Apr; 39(8):883-93. PubMed ID: 24612251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: apoptosis and hepatic fibrosis in chronic hepatitis B--authors' reply.
    Chao D; Nguyen MH
    Aliment Pharmacol Ther; 2014 May; 39(9):997. PubMed ID: 24689348
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural regression of fibrosis in chronic hepatitis B.
    Ohkoshi S; Hirono H; Watanabe K; Hasegawa K; Kamimura K; Yano M
    World J Gastroenterol; 2016 Jun; 22(24):5459-66. PubMed ID: 27350724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of steatohepatitis in chronic hepatitis B patients and its impact on disease severity and treatment response.
    Charatcharoenwitthaya P; Pongpaibul A; Kaosombatwattana U; Bhanthumkomol P; Bandidniyamanon W; Pausawasdi N; Tanwandee T
    Liver Int; 2017 Apr; 37(4):542-551. PubMed ID: 27740738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: prognostication of chronic hepatitis B - are Fibrotest and Fibroscan the final answers? Authors' reply.
    de Lédinghen V; Vergniol J
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1114. PubMed ID: 23656420
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease.
    Sumi H; Yokosuka O; Seki N; Arai M; Imazeki F; Kurihara T; Kanda T; Fukai K; Kato M; Saisho H
    Hepatology; 2003 Jan; 37(1):19-26. PubMed ID: 12500184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of liver stiffness measured by FibroTouch and FibroScan with Ishak fibrosis score in patients with chronic hepatitis B].
    Chen GF; Ping J; Gu HT; Zhao ZM; Zhou Y; Xing F; Tao YY; Mu YP; Liu P; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):145-150. PubMed ID: 28297803
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B--authors' reply.
    Hsiang J; Wong GL; Chan HL; Wong VW
    Aliment Pharmacol Ther; 2014 Oct; 40(8):983. PubMed ID: 25229812
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.
    Wong VW; Wong GL; Yu J; Choi PC; Chan AW; Chan HY; Chu ES; Cheng AS; Chim AM; Chan FK; Sung JJ; Chan HL
    Am J Gastroenterol; 2010 Jan; 105(1):132-8. PubMed ID: 19809411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of FibroScan in liver fibrosis evaluation in patients with chronic hepatitis B virus infection and related influencing factors].
    Xie QX; Xu N; Jiang XP; Zhang YF; Zhang ZH; Li JB; Hu XY; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):659-664. PubMed ID: 27788721
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
    Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY
    J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: moderate-to-severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Authors' reply.
    Shen F; Fan JG
    Aliment Pharmacol Ther; 2019 Sep; 50(5):617-618. PubMed ID: 31414530
    [No Abstract]   [Full Text] [Related]  

  • 15. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: the association between chronic viral hepatitis and metabolic syndrome - Authors' reply.
    Kuo YH; Lu SN
    Aliment Pharmacol Ther; 2019 Jan; 49(2):233-234. PubMed ID: 30589967
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
    Rinaldi L; Ascione A; Messina V; Rosato V; Valente G; Sangiovanni V; Zampino R; Marrone A; Fontanella L; de Rosa N; Orabona P; Buonomo C; Chirianni A; Adinolfi LE; Piai G
    Infection; 2018 Apr; 46(2):231-238. PubMed ID: 29335905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B.
    Lu Q; Lu C; Li J; Ling W; Qi X; He D; Liu J; Wen T; Wu H; Zhu H; Luo Y
    Radiology; 2016 Jul; 280(1):290-9. PubMed ID: 26885682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: apoptosis and hepatic fibrosis in chronic hepatitis B.
    Kountouras J; Patsiaoura K; Zavos C; Chatzopoulos D; Katsinelos P; Tantsi N; Polyzos SA; Giouleme O; Gigi E; Deretzi G; Simeonidou C; Grigoriadis N; Boura P
    Aliment Pharmacol Ther; 2014 May; 39(9):996. PubMed ID: 24689347
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B.
    Cheng JY; Wong VW; Tse YK; Chim AM; Chan HL; Wong GL
    Hepatology; 2016 Nov; 64(5):1507-1517. PubMed ID: 27680510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.